Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20

Blood

Volumn 83, Issue 2, 1994, Pages 435-445

  Reff, Mitchell E ^a   Carner, Kristin ^a   Chambers, Karen S ^a   Chinn, Paul C ^a   Leonard, John E ^a   Raab, Ron ^a   Newman, Roland A ^a   Hanna, Nabil ^a   Anderson, Darrell R ^a  

^a BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE ANTIGEN; CD20 ANTIGEN; CHIMERIC PROTEIN; COMPLEMENT COMPONENT C1Q; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN HEAVY CHAIN; IMMUNOGLOBULIN KAPPA CHAIN; MONOCLONAL ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIGEN BINDING; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BONE MARROW; CHO CELL; COMPLEMENT DEPENDENT CYTOTOXICITY; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE CELL; LYMPHOCYTE DEPLETION; MACACA; MOUSE; NONHUMAN; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL;

EID: 0028057250     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v83.2.435.435     Document Type: Article

References (30)

1. Calvert JE, Maruyama S, Tedder TF, Webb CF, Cooper MD: Cellular events in the differentiation of antibody secreting cells. Semin Hematol 21:226, 1984
2. Valentine MA, Meier KE, Rossie S, Clark EA: Phosphorylatin of the CD20 phosphoprotein in resting B lymphocytes. J Biol Chem 264:11282, 1989
3. Nadler LM, Korsmeyer SJ, Anderson KC, Boyd AW, Slaughenhoupt B, Park E, Jansen J, Coral F, Mayer RJ, Dalla SE, Ritz J, Schlossman SF: B cell origin of non-T cell acute Iymphoblastic leukemia. J Clin Invest 74:332, 1984
4. Tedder TF, Boyd AW, Freedman AS, Nadler LM, Schlossman SF: The B cell surface molecule B1 is functionally linked with B cell activation and differentiation. J Immunol 135:973, 1985
5. Tedder TF, Forsgren A, Boyd AW, Nadler LM, Schlossman SF: Antibodies reactive with the B1 molecule inhibit cell cycle progression but not activation of human B lymphocytes. Eur J Immunol 16:881, 1986
6. 0 to the G, phase of the cell cycle. J Immunol 135:3795, 1985
7. Clark EA, Shu G, Ledbetter JA: Role of the Bp35 cell surface polypeptide in human B-cell activation. Proc Natl Acad Sci USA 82:1766, 1985
8. Press OW, Appelbaum F, Ledbetter JA, Martin PJ, Zarling J, Kidd P, Thomas ED: Monoclonal antibody 1F5 (anti-CD20) serotherapy of human B-cell lymphomas. Blood 69:584, 1987
9. Einfeld DA, Brown JP, Valentine MA, Clark EA, Ledbetter JA: Molecular cloning of the human B cell CD20 receptor predicts a hydrophobic protein with multiple transmembrane domains. EMBO J 7:711, 1988
10. Liu AY, Robinson R Jr, Murray ED, Ledbetter JA, Hellström I, Hellström KE: Production of a mouse-human chimeric monoclonal antibody to CD20 with potent Fc-dependent biologic activity. J Immunol 139:3521, 1987
11. Adams RA, Flowers A, Davis BJ: Direct implantation and serial transplantation of human acute Iymphoblastic leukemia in hamsters, SB-2. Cancer Res 28:1121, 1968
12. Shulman M, Wilde CD, Kohler G: A better cell line for making hybridomas secreting specific antibodies. Nature 276:269, 1978
13. Markwell MAK: A new solid-state reagent to iodinate proteins I. conditions for the efficient labeling of anti-serum. Anal Biochem 125:427, 1982
14. Chomczynki P, Nicoletta S: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
15. Kabat EA, Wu TT, Perry HM, Gottesman KS, Foeller C: Sequences of Proteins of Immunological Interest (ed 5). NIH Publication No. 91-3242. Bethesda, MD, National Institutes of Health, 1991
16. Urlaub G, Mitchell PJ, Kas E, Chasin LA, Funanage VL, Myoda T, Hamlin J: Effect of gamma rays at the dihydrofolate reductast locus: Deletions and inversions. Somat Cell Mol Genet 16: 555, 1986
17. Adams RA: Formal discussion: The role of transplantation in the experimental investigation of human leukemia and lymphoma. Cancer Res 27:2479, 1967
18. 51Cr-labelled allogeneic target cells in vitro: inhibition by isoantibody and by drugs. Immunology 14:181, 1968
19. Ling NR, Maclennan ICM, Mason DY: B-cell and plasma cell antigens: New and previously defined clusters, in McMichael AJ (ed): Leucocyte Typing III: White Cell Differentiations Antigens. Oxford, UK, Oxford University, 1987, p 302
20. Colbere-Garapin F, Horodniceanu F, Kourilsky P, Garaphin AC: A new dominant hybrid selective marker for higher eukaryotic cells. J Mol Biol 150:1, 1981
21. Subramani S, Mulligan R, Berg P: Expression of the mouse dihydrofolate reductase complementary deoxyribonucleic acid in simain virus 40 vectors. Mol Cell Biol 9:854, 1981
22. Kaufman R, Sharp PA: Amplification and expression of sequences cotransfected with a modular dihydrofolate reductase complementary DNA gene. J Mol Biol 159:601, 1982
23. Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM: Monoclonal antibody-based therapies of leukemia and Iymphoma. Blood 80:863, 1992
24. Grossbard ML, Freedman AS, Ritz J, Coral F, Goldmacher VS, Eliseo L, Spector N, Dear K, Lambert JM, Blattler WA, Taylor JA, Nadler LM: Serotherapy of B-cell neoplasms with anti-B4-blocked ricin: A phase I trial of daily bolus infusion. Blood 79:576, 1992
25. Press OW, Eary JF, Badger CC, Appelbaum F, Levy R, Miller R, Brown S, Nelp WB, Krohn KA, Fisher D, DeSantes K, Porter B, Kidd P, Thomas ED, Bernstein ID: Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody. J Clin Oncol 7:1027, 1989
26. Nadler LM, Stashenko P, Hardy R, Kaplan WD, Button LN, Kufe DW, Antman KH, Schlossman SF: Serotherapy of a patient with a monoclonal antibody directed against a human lymphoma-associated antigen. Cancer Res 40:3147, 1980
27. Meeker TC, Lowder J, Maloney DG, Miller RA, Thielemans K, Warnke R, Levy R: A clinical trial of anti-idiotype therapy for B-cell malignancy. Blood 65:1349, 1985
28. Brown SL, Miller RA, Horning SJ, Czerwinski D, Hart SM, McElderry R, Basham T, Warnke RA, Merigan TC, Levy R: Treatment of B-cell lymphomas with anti-idiotype antibodies alone and in combination with alpha interferon. Blood 73:651, 1989
29. Hale G, Clark MR, Marcus R, Winter G, Dyer MJS, Phillips JM, Riechmann W: Remission induction in non-Hodgkin lymphoma with reshaped human monoclonal antibody campath-1H. Lancet 332:1394, 1988
30. Anderson KC, Ritz J, Takvorian T, Coral F, Daley H, Gorgone BC, Freedman AS, Canellos GP, Schlossman SF, Nadler LM: Hematologic engraftment and immune reconstitution posttransplantation with anti-B1 purged autologous bone marrow. Blood 69:597, 1987